Generics makers should prepare for FDA labeling rule

07/15/2013 | Forbes

Manufacturers of generic drugs should expect and plan for increasing regulation. A forthcoming FDA rule could let them change product labeling in the same way brand-name drugmakers do, Richard Levick writes. Generic-drug makers could be held liable if consumers are injured by their products, or if their label information and warnings fall short, he writes.

View Full Article in:


Published in Briefs: